 The art of biotech investing requires a great deal of scientific knowledge, awareness of financials, and patience in waiting for clinical trials to come to fruition. Today, lets examine two of the best biotech stocks in the industry; both are companies making rapid progress in treating patients with significant medical needs. Compugen NASDAQ: CGEN specializes in clinical-stage cancer immunotherapies, which have proprietary algorithms used to detect specific sequences within protein receptors that regulate the immune system and inhibit autoimmune activity. 